The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: A systematic review and meta-analysis

REFERENCES

• References marked with an asterisk (*) indicate studies included in the meta-analysis.
   Google Scholar
• *Allain, H., Bentue-Ferrer, D., Tarral, A., & Gandon, J.-M. (2003). Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo. European Journal of Clinical Pharmacology, 59(3), 179–188.
   PubMed Web of Science ®Google Scholar
• Anderson-Hanley, C., Sherman, M. L., Riggs, R., Agocha, V. B., & Compas, B. E. (2003). Neuropsychological effects of treatments for adults with cancer: A meta-analysis and review of the literature. Journal of the International Neuropsychological Society, 9(7), 967–982.
   PubMed Web of Science ®Google Scholar
• Barker, M. J., Greenwood, K. M., Jackson, M., & Crowe, S. F. (2004). Cognitive effects of long-term benzodiazepine use: A meta-analysis. CNS Drugs, 18(1), 37–48.
   PubMed Web of Science ®Google Scholar
• Barker, M. J., Jackson, M., Greenwood, K. M., & Crowe, S. F. (2003). Cognitive effects of benzodiazepine use: A review. Australian Psychologist, 38(3), 202–213.
   Web of Science ®Google Scholar
• *Bensimon, G., Foret, J., Warot, D., Lacomblez, L., Thiercelin, J. F., & Simon, P. (1990). Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo. British Journal of Clinical Pharmacology, 30(3), 463–469.
   PubMed Web of Science ®Google Scholar
• *Blin, O., Micallef, J., Audebert, C., & Legangneux, E. (2006). A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers. Journal of Clinical Psychopharmacology, 26(3), 284–289.
   PubMed Web of Science ®Google Scholar
• *Boyle, J., Trick, L., Johnsen, S., Roach, J., & Rubens, R. (2008). Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone. Human Psychopharmacology, 23(5), 385–397. doi:10.1002/hup.936
   PubMed Web of Science ®Google Scholar
• Chilcott, L. A., & Shapiro, C. M. (1996). The socioeconomic impact of insomnia. Pharmacoeconomics, 10(1), 1–14.
   PubMedGoogle Scholar
• Cooper, H. (2010). Research synthesis and meta-analysis. Thousand Oaks, CA: Sage.
   Google Scholar
• Cotroneo, A., Gareri, P., Nicoletti, N., Lacava, R., Grassone, D., Maina, E., … Cabodi, S. (2007). Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people. Archives of Gerontology and Geriatrics, 44(Suppl. 1), 121–124. doi:10.1016/j.archger.2007.01.018
   Web of Science ®Google Scholar
• Danjou, P., Paty, I., Fruncillo, R., Worthington, P., Unruh, M., Cevallos, W., & Martin, P. (1999). A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening. British Journal of Clinical Pharmacology, 48(3), 367–374.
   PubMed Web of Science ®Google Scholar
• Diekelmann, S., & Born, J. (2010). The memory function of sleep. Nature Reviews Neuroscience, 11(2), 114–126.
   PubMed Web of Science ®Google Scholar
• *Dingemanse, J., Bury, M., Bock, J., & Joubert, P. (1995). Comparative pharmacodynamics of Ro 41–3696, a new hypnotic, and zolpidem after night-time administration to healthy subjects. Psychopharmacology, 122(2), 169–174.
   PubMed Web of Science ®Google Scholar
• Doghramji, P. P. (2001). Treatment of insomnia with zaleplon, a novel sleep medication. International Journal of Clinical Practice, 55(5), 329–334.
   PubMed Web of Science ®Google Scholar
• Dündar, Y., Dodd, S., Strobl, J., Boland, A., Dickson, R., & Walley, T. (2004). Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: A systematic review and meta-analysis. Human Psychopharmacology: Clinical and Experimental, 19(5), 305–322.
   PubMed Web of Science ®Google Scholar
• Ebert, B., Wafford, K. A., & Deacon, S. (2006). Treating insomnia: Current and investigational pharmacological approaches. Pharmacology & Therapeutics, 112(3), 612–629.
   PubMed Web of Science ®Google Scholar
• *Fairweather, D. B., Kerr, J. S., & Hindmarch, I. (1992). The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers. European Journal of Clinical Pharmacology, 43(6), 597–601.
   PubMed Web of Science ®Google Scholar
• *Gieschke, R., Cluydts, R., Dingemanse, J., De Roeck, J., & De Cock, W. (1994). Effects of bretazenil vs. zolpidem and placebo on experimentally induced sleep disturbance in healthy volunteers. Methods & Findings in Experimental & Clinical Pharmacology, 16(9), 667–675.
   PubMed Web of Science ®Google Scholar
• *Harrison, C., Subhan, Z., & Hindmarch, I. (1984). Residual effects of zopiclone and benzodiazepine hypnotics on psychomotor performance related to car driving. Drugs under Experimental and Clinical Research, 11(12), 823–829.
   Google Scholar
• Harvey, S. T., & Taylor, J. E. (2010). A meta-analysis of the effects of psychotherapy with sexually abused children and adolescents. Clinical Psychology Review, 30(5), 517–535.
   PubMed Web of Science ®Google Scholar
• *Hemmeter, U., Muller, M., Bischof, R., Annen, B., & Holsboer-Trachsler, E. (2000). Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers. Psychopharmacology, 147(4), 384–396. doi:10.1007/s002130050007
   PubMed Web of Science ®Google Scholar
• Hindmarch, I., Legangneux, E., Stanley, N., Emegbo, S., & Dawson, J. (2006). A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers. British Journal of Clinical Pharmacology, 62(5), 538–545.
   PubMed Web of Science ®Google Scholar
• Hoffmann, F. (2013). Perceptions of German GPs on benefits and risks of benzodiazepines and Z-drugs. Swiss Medical Weekly, 143, w13745.
   PubMed Web of Science ®Google Scholar
• Hollingworth, S. A., & Siskind, D. J. (2010). Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiology and Drug Safety, 19(3), 280–288.
   PubMed Web of Science ®Google Scholar
• Huedo-Medina, T. B., Kirsch, I., Middlemass, J., Klonizakis, M., & Siriwardena, A. N. (2011). Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: Meta-analysis of data submitted to the Food and Drug Administration. BMJ: British Medical Journal, 345, e8343. doi:10.1136/bmj.e8343
   Google Scholar
• Hutchinson, A. D., & Mathias, J. L. (2007). Neuropsychological deficits in frontotemporal dementia and Alzheimer’s disease: A meta-analytic review. Journal of Neurology, Neurosurgery & Psychiatry, 78(9), 917–928.
   PubMed Web of Science ®Google Scholar
• Leufkens, T. R., Lund, J. S., & Vermeeren, A. (2009). Highway driving performance and cognitive functioning the morning after bedtime and middle-of-the-night use of gaboxadol, zopiclone and zolpidem. Journal of Sleep Research, 18(4), 387–396. doi:10.1111/j.1365-2869.2009.00746.x
   PubMed Web of Science ®Google Scholar
• *Leufkens, T. R., & Vermeeren, A. (2009). Highway driving in the elderly the morning after bedtime use of hypnotics: A comparison between temazepam 20 mg, zopiclone 7.5 mg, and placebo. Journal of Clinical Psychopharmacology, 29(5), 432–438. doi:10.1097/JCP.0b013e3181b57b43
   PubMed Web of Science ®Google Scholar
• Lezak, M. D., Howieson, D. B., Bigler, E. D., & Tranel, D. (2012). Neuropsychological assessment (5th ed.). New York, NY: Oxford University Press.
   Google Scholar
• Lipsey, M. W., & Wilson, D. B. (2001). Practical meta-analysis. Thousand Oaks, CA: Sage.
   Google Scholar
• *Mattila, M., Aranko, K., & Paakkari, I. (1994). Effects of psychotropic drugs on digit substitution: Comparison of the computerized symbol-digit substitution and traditional digit-symbol substitution tests. Journal of Psychopharmacology, 8(2), 81–87. doi:10.1177/026988119400800202
   PubMed Web of Science ®Google Scholar
• *Mattila, M., & Mattila-Evenden, M. (1997). Effects of alcohol and hypnosedative drugs on digit-symbol substitution: Comparison of two different computerized tests. Journal of Psychopharmacology, 11(4), 313–317. doi:10.1177/026988119701100405
   PubMed Web of Science ®Google Scholar
• Mednick, S. C., McDevitt, E. A., Walsh, J. K., Wamsley, E., Paulus, M., Kanady, J. C., & Drummond, S. P. (2013). The critical role of sleep spindles in hippocampal-dependent memory: A pharmacology study. The Journal of Neuroscience, 33(10), 4494–4504.
   PubMed Web of Science ®Google Scholar
• *Melendez, J., Galli, I., Boric, K., Ortega, A., Zuniga, L., Henriquez-Roldan, C. F., & Cardenas, A. M. (2005). Zolpidem and triazolam do not affect the nocturnal sleep-induced memory improvement. Psychopharmacology, 181(1), 21–26.
   PubMed Web of Science ®Google Scholar
• *Mets, M. A., de Vries, J. M., de Senerpont Domis, L. M., Volkerts, E. R., Olivier, B., & Verster, J. C. (2011). Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance, and mood in healthy adult subjects. Sleep: Journal of Sleep and Sleep Disorders Research, 34(10), 1327–1334.
   Google Scholar
• *Morgan, P. T., Kehne, J. H., Sprenger, K. J., & Malison, R. T. (2010). Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans. Journal of Sleep Research, 19 (1, Pt. 2), 157–164. doi:10.1111/j.1365-2869.2009.00757.x
   PubMed Web of Science ®Google Scholar
• National Institute for Clinical Excellence. (2004). Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia (Technology Appraisal Guide 77). London: NICE.
   Google Scholar
• *Quera-Salva, M. A., McCann, C., Boudet, J., Frisk, M., Borderies, P., & Meyer, P. (1994). Effects of zolpidem on sleep architecture, night time ventilation, daytime vigilance and performance in heavy snorers. British Journal of Clinical Pharmacology, 37(6), 539–543.
   PubMed Web of Science ®Google Scholar
• *Roehrs, T., Merlotti, L., Zorick, F., & Roth, T. (1994). Sedative, memory, and performance effects of hypnotics. Psychopharmacology, 116(2), 130–134.
   PubMed Web of Science ®Google Scholar
• Rosenthal, R. (1995). Writing meta-analytic reviews. Psychological Bulletin, 118(2), 183.
   Web of Science ®Google Scholar
• Sicard, B. A., Trocherie, S., Moreau, J., Vieillefond, H., & Court, L. A. (1993). Evaluation of zolpidem on alertness and psychomotor abilities among aviation ground personnel and pilots. Aviation Space & Environmental Medicine, 64(5), 371–375.
   PubMed Web of Science ®Google Scholar
• *Silva, A., Collao, A., Orellana, M., Meléndez, J., Caviedes, P., & Cárdenas, A. M. (2003). Zopiclone, but not brotizolam, impairs memory storage during sleep. Neuroscience Research, 47(2), 241–243.
   PubMed Web of Science ®Google Scholar
• Siriwardena, A. N., Qureshi, Z., Gibson, S., Collier, S., & Latham, M. (2006). GPs’ attitudes to benzodiazepine and “Z-drug” prescribing: A barrier to implementation of evidence and guidance on hypnotics. British Journal of General Practice, 56(533), 964–967.
   PubMed Web of Science ®Google Scholar
• Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. The Clinical Neuropsychologist, 20(1), 76–89.
   PubMed Web of Science ®Google Scholar
• Stone, B. M., Turner, C., Mills, S. L., Paty, I., Patat, A., Darwish, M., & Danjou, P. (2002). Noise-induced sleep maintenance insomnia: Hypnotic and residual effects of zaleplon. British Journal of Clinical Pharmacology, 53(2), 196–202.
   PubMed Web of Science ®Google Scholar
• Strauss, E., Sherman, E. M. S., & Spreen, O. (2006). A compendium of neuropsychological tests: Administration, norms, and commentary (3rd ed.). New York, NY: Oxford University Press.
   Google Scholar
• *Tafti, M., Besset, A., & Billiard, M. (1992). Effects of zopiclone on subjective evaluation of sleep and daytime alertness and on psychomotor and physical performance tests in athletes. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 16(1), 55–63.
   PubMed Web of Science ®Google Scholar
• Terzano, M., Rossi, M., Palomba, V., Smerieri, A., & Parrino, L. (2003). New drugs for insomnia: Comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Safety, 26(4), 261–282.
   PubMed Web of Science ®Google Scholar
• Thomas, M., Sing, H., Belenky, G., Holcomb, H., Mayberg, H., Dannals, R., … Rowland, L. (2008). Neural basis of alertness and cognitive performance impairments during sleepiness: I. Effects of 24 h of sleep deprivation on waking human regional brain activity. Journal of Sleep Research, 9(4), 335–352.
   Google Scholar
• *Uchiumi, M., Isawa, S., Suzuki, M., & Murasaki, M. (2000). The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance. Nihon Shinkei Seishin Yakurigaku Zasshi, 20(3), 123–130.
   PubMedGoogle Scholar
• *Vermeeren, A., Riedel, W. J., van Boxtel, M. P. J., Darwish, M., Paty, I., & Patat, A. (2002). Differential residual effects of zaleplon and zopiclone on actual driving: A comparison with a low dose of alcohol. Sleep, 25(2), 224–231.
   PubMed Web of Science ®Google Scholar
• Warot, D., Bensimon, G., Danjou, P., & Puech, A. J. (1987). Comparative effects of zopiclone, triazolam and placebo on memory and psychomotor performance in healthy volunteers. Fundamental & Clinical Pharmacology, 1(2), 145–152.
   PubMed Web of Science ®Google Scholar